Remicade Quick Reference Guide
Generic name
- Infliximab
Date approved
- 1998
Manufacturer
- Centocor
Status
- On the market
- 8/2005 Warning letter
Approved uses
- Rheumatoid arthritis
- Crohn's disease
Off-label uses
- Inflammatory disease
Serious side effects
- Cancer
- Lymphoma
- Abnormal bleeding
- Infections
- Nervous system disorders
- Tuberculosis
Remicade
What is Remicade?
Remicade (Infliximab) is a monoclonal antibody manufactured by Centocor, a subsidiary of Johnson & Johnson.
Who takes it, and for what condition?
Patients who suffer from rheumatoid arthritis or Crohn's disease take the immune-suppressing drug Remicade.
How does Remicade work?
Remicade blocks tumornecrosis factor (TNF), which is made by certain blood cells in the body. By blocking the TNF, Remicade may reduce the inflammation associated with rheumatoid arthritis.
Remicade patients have suffered lymphoma, a type of cancer, at three times the rate of the general public. The drug also has been associated with blood disorders, central nervous system disorders and tuberculosis.
What can you do?
If you or a loved one took Remicade and suffered side effects, please call our toll-free number (1-888-341-1405) to discuss your case with one of our Remicade injury lawyers.
Trust our Massachusetts products liability attorneys to help
Contact the Boston law firm of Thornton & Naumes LLP online or at 1-888-341-1405 for a free consultation with a recognized leader in Massachusetts defective drug litigation. You have nothing to risk. We offer a fair and accurate assessment of your case, and, perhaps, some hope.














